Idarubicin plus ARA-C followed by allogeneic or autologous bone marrow transplantation in advanced acute lymphoblastic leukemia

Bone Marrow Transplant. 1991:7 Suppl 2:38.

Authors

W Arcese¹, G Meloni, F Giona, M L Vegna, A M Testi, L Annino, A P Iori, M Carotenuto, L Resegotti, E Madon, et al.

Affiliation

¹ Department of Human Biopathology, University La Sapienza, Rome.

PMID: 1878711

No abstract available

Publication types

Clinical Trial
Comparative Study
Multicenter Study

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Bone Marrow Transplantation*
Combined Modality Therapy
Cytarabine / administration & dosage
Humans
Idarubicin / administration & dosage
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma / surgery
Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy*
Prospective Studies
Remission Induction
Transplantation, Autologous
Transplantation, Homologous

Substances

Cytarabine
Idarubicin